Canadian bioinformaticians develop new tools to create 3D structure of RNA. [ + ]

Progen goes into Phase III and ChemGenex Phase II, Bionomics looks at anxiety, Clinuvel gets orphan designation and Avexa announces collaboration and good results. [ + ]

Planetary scientist asks the question: should we expect extraterrestrials to be as stupid as we are? [ + ]

Thermo Fisher Scientific has opened a state-of-the-art facility in Adelaide, SA.

Turkish researchers have conducted a small clinical trial of breast cancer drug tamoxifen in people with bipolar disorder. [ + ]

Blood platelet protein regulates serotonin transporter and determines blood serotonin levels. [ + ]

C. elegans caps its chromosomes with a G-tail off the right and a C-tail off the left. [ + ]

Two papers by WAIMR scientists unlock how genes and hormones contribute to red blood cell formation. [ + ]

UQ researchers are developing a predictive test for type 1 diabetes by tracing activation of the NF-kappa B pathway. [ + ]

What's New in LAB Technology editor Janette Woodhouse reports on the Australian contingent at Pittcon 2008.

Elizabeth Blackburn accepts her L'Oreal women in science award in Paris. [ + ]

Many companies release their latest products at Pittcon. This year, as part of the swing away from biotechnology and towards environmental sustainability testing, there is an abundance of bio-diesel and bio-fuel analysers hitting the market.

More effective treatments for brain cancer will be developed at a tumour-cell testing facility opened yesterday at The University of Queensland’s Queensland Brain Institute.

US researchers discover how certain proteins control the process of programmed cell death. [ + ]

Biotechnology seems to have taken a back seat this year at Pittcon, the huge annual laboratory conference and exposition held in the US.